Bookmark and Share
octanoic acid (CID 379) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(1)
 
 
Inactive(981)
 
 
Inconclusive(35)
 
 
Unspecified(31)
 
 
Top Targets:
NR LBD PPAR(28)
 
 
 
NR LBD ER(25)
 
 
 
NR LBD AR(25)
 
 
 
NR LBD TR(17)
 
 
NR LBD GR(16)
 
 
 
BioAssay Types:
Confirmatory(594)
 
 
 
 
Screening(266)
 
 
 
 
Literature(78)
 
 
 
 
Summary(63)
 
 
 
BioActivity Types:
Potency(560)
 
 
 
 
IC50(9)
 
 
 
Ki(3)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 621    Data Row: 1048   Total Pages: 21   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID85272331]
Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1) [AID504766, Type: screening]nuclear receptor subfamily 0 group B member 1 [Homo sapiens] [gi:5016090]
View
2
[SID103329806]
Ki 5.41TP_TRANSPORTER: inhibition of Ochratoxin A uptake in OAT1-expressing S2 cells [AID678821, Type: other]Solute carrier family 22 member 6 [gi:74762955]
View
3
[SID103329806]
Ki 8.6TP_TRANSPORTER: inhibition of Ochratoxin A uptake in OAT3-expressing S2 cells [AID678814, Type: other]Solute carrier family 22 member 8 [gi:74730587]
View
4
[SID103329806]
Ki 235.5TP_TRANSPORTER: inhibition of Ochratoxin A uptake in OAT4-expressing S2 cells [AID678972, Type: other]Solute carrier family 22 member 11 [gi:74734337]
View
5
[SID103329806]
IC50 53500Inhibitory activity on germination of Bacillus subtilis PCI219 spores was determined. [AID40623, Type: Literature]
View
6
[SID103329806]
IC50 53703.2Inhibition of Bacillus subtilis spore germination, activity is expressed as log of the reciprocal of Casida's I50 value. [AID40935, Type: Literature]
View
7
[SID103329806]
Inhibition of Bacillus subtilis PCI219 spore germination, expressed as log 1/I50 [AID40936, Type: Literature]
View
8
[SID103329806]
Antibacterial activity against Bacillus subtilis ATCC 9372 after 2 days by broth dilution method [AID359935, Type: other]
View
9
[SID103329806]
Antibacterial activity against Brevibacterium ammoniagenes ATCC 6872 after 2 days by broth dilution method [AID359936, Type: other]
View
10
[SID103329806]
Antibacterial activity against Staphylococcus aureus ATCC 12598 after 2 days by broth dilution method [AID359937, Type: other]
View
11
[SID103329806]
Antibacterial activity against Streptococcus mutans ATCC 125175 after 2 days by broth dilution method [AID359938, Type: other]
View
12
[SID103329806]
Antibacterial activity against Propionibacterium acnes ATCC 11827 after 2 days by broth dilution method [AID359939, Type: other]
View
13
[SID103329806]
Antibacterial activity against Escherichia coli ATCC 9637 after 2 days by broth dilution method [AID359940, Type: other]
View
14
[SID103329806]
Antibacterial activity against Pseudomonas aeruginosa ATCC 10145 after 2 days by broth dilution method [AID359941, Type: other]
View
15
[SID103329806]
Antibacterial activity against Enterobacter aerogenes ATCC 13048 after 2 days by broth dilution method [AID359942, Type: other]
View
16
[SID103329806]
Antifungal activity against Saccharomyces cerevisiae ATCC 7754 after 2 days by broth dilution method [AID359943, Type: other]
View
17
[SID103329806]
Antifungal activity against Candida utilis ATCC 9226 after 2 days by broth dilution method [AID359944, Type: other]
View
18
[SID103329806]
Antibacterial activity against Proteus vulgaris ATCC 13315 after 2 days by broth dilution method [AID359945, Type: other]
View
19
[SID103329806]
Antifungal activity against Pityrosporum ovale ATCC 14521 after 3 days by broth dilution method [AID359946, Type: other]
View
20
[SID103329806]
Antifungal activity against Penicillium chrysogenum ATCC 10106 after 5 days by broth dilution method [AID359947, Type: other]
View
21
[SID103329806]
Antifungal activity against Trichophyton mentagrophytes ATCC 18748 after 5 days by broth dilution method [AID359948, Type: other]
View
22
[SID103329806]
Antioxidant activity assessed as formazan formation induced absorbance changes at 25 ppm at 570 nm at 37 degC for 6 hrs by MTT assay [AID492140, Type: Literature]
View
23
[SID17388833]
qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838, Type: other]
View
24
[SID17389655]
qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838, Type: other]
View
25
[SID17389655]
qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749, Type: Literature]
View
26
[SID103329806]
Dissociation constant (pKa) [AID25611, Type: Literature]
View
27
[SID103329806]
Partition coefficient (logD7.2) [AID26261, Type: Literature]
View
28
[SID103329806]
Partition coefficient (logP) [AID26793, Type: Literature]
View
29
[SID85272331]
Potency qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory]acid sphingomyelinase [Homo sapiens] [gi:179095]
View
30
[SID103329806]
Specific activity of expressed human recombinant UGT1A10 [AID624613, Type: Literature]UDP-glucuronosyltransferase 1-10 [gi:29839636]
View
31
[SID103329806]
Specific activity of expressed human recombinant UGT1A8 [AID624611, Type: Literature]UDP-glucuronosyltransferase 1-8 [gi:29839637]
View
32
[SID103329806]
TP_TRANSPORTER: inhibition of Ochratoxin A uptake (OTA: 1 uM, Octanoate: 200 uM) in Xenopus laevis oocytes [AID681800, Type: other]Solute carrier family 22 member 6 [gi:81886651]
View
33
[SID85272331]
Potency 0.2311A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. [AID624297, Type: confirmatory]geminin [Homo sapiens] [gi:7705682]
View
34
[SID144210663]
Potency-Replicate_1 1.23qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway [AID743075, Type: confirmatory]estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627]
View
35
[SID144204596]
Potency-Replicate_1 9.5205qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway [AID743069, Type: confirmatory]estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627]
View
36
[SID144208477]
Potency-Replicate_1 37.5335qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway [AID743069, Type: confirmatory]estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627]
View
37
[SID144208477]
Potency-Replicate_1 53.0175qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway [AID743075, Type: confirmatory]estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627]
View
38
[SID144208477]
Potency-Replicate_1 58.9612qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability [AID651634, Type: confirmatory]
View
39
[SID144208477]
Potency-Replicate_1 qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line [AID743012, Type: confirmatory]
View
40
[SID144208477]
Potency-Replicate_1 qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line [AID743014, Type: confirmatory]
View
41
[SID144208477]
Potency-Replicate_1 qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line [AID743015, Type: confirmatory]
View
42
[SID144208477]
Potency-Replicate_1 qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway - cell viability counter screen [AID743033, Type: confirmatory]
View
43
[SID144208477]
Potency-Replicate_1 qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen [AID743041, Type: confirmatory]
View
44
[SID144208477]
Potency-Replicate_1 qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen [AID743064, Type: confirmatory]
View
45
[SID17388833]
Potency qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay [AID651754, Type: confirmatory]
View
46
[SID17388833]
Potency qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay [AID651755, Type: confirmatory]
View
47
[SID85272331]
Potency qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen [AID624418, Type: confirmatory]
View
48
[SID85272331]
Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease [AID624483, Type: screening]
View
49
[SID144208477]
Potency-Replicate_1 qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen [AID720693, Type: confirmatory]
View
50
[SID144208477]
Potency-Replicate_1 qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen [AID743081, Type: confirmatory]
View